N
Neumora Therapeutics Inc
NASDAQ:NMRA
Neumora Therapeutics Inc
NASDAQ:NMRA
Price:
2.5
USD
1.21%
Market Closed
Market Cap:
$412m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Neumora Therapeutics Inc
NASDAQ:NMRA
|
US |
|
T
|
Tod's SpA
LSE:0NV4
|
IT |
|
CNO Financial Group Inc
NYSE:CNO
|
US |
Cash Flow Statement
Cash Flow Statement
Neumora Therapeutics Inc
Neumora Therapeutics Inc
Currency: USD
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||
| Net Income |
(132)
|
(230)
|
(237)
|
(265)
|
(278)
|
(131)
|
(123)
|
(132)
|
(185)
|
(236)
|
(254)
|
(274)
|
(294)
|
(244)
|
(258)
|
(252)
|
(236)
|
|
| Depreciation & Amortization |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Stock-Based Compensation |
4
|
5
|
4
|
5
|
6
|
8
|
9
|
10
|
16
|
17
|
22
|
33
|
36
|
40
|
42
|
36
|
32
|
|
| Other Non-Cash Items |
78
|
166
|
162
|
176
|
177
|
22
|
10
|
10
|
16
|
81
|
86
|
95
|
98
|
38
|
39
|
36
|
32
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Change in Working Capital |
(2)
|
1
|
(1)
|
(4)
|
(5)
|
(7)
|
(3)
|
1
|
(0)
|
(9)
|
(6)
|
(20)
|
11
|
23
|
19
|
20
|
(5)
|
|
| Cash from Operating Activities |
(56)
N/A
|
(63)
-13%
|
(75)
-21%
|
(92)
-22%
|
(105)
-14%
|
(115)
-9%
|
(116)
-1%
|
(120)
-4%
|
(168)
-40%
|
(163)
+3%
|
(173)
-6%
|
(198)
-15%
|
(184)
+7%
|
(183)
+1%
|
(199)
-9%
|
(196)
+2%
|
(209)
-7%
|
|
| Investing Cash Flow | ||||||||||||||||||
| Capital Expenditures |
(2)
|
(2)
|
(1)
|
(14)
|
(14)
|
(14)
|
(0)
|
(0)
|
(0)
|
(5)
|
(5)
|
(5)
|
(5)
|
(1)
|
0
|
0
|
(0)
|
|
| Other Items |
(10)
|
1
|
0
|
(73)
|
(164)
|
(155)
|
(79)
|
36
|
60
|
69
|
(83)
|
(86)
|
47
|
(70)
|
124
|
133
|
27
|
|
| Cash from Investing Activities |
(11)
N/A
|
(1)
+92%
|
(1)
+13%
|
(86)
-10 444%
|
(177)
-105%
|
(168)
+5%
|
(80)
+53%
|
36
N/A
|
59
+67%
|
64
+8%
|
(88)
N/A
|
(91)
-3%
|
42
N/A
|
(71)
N/A
|
124
N/A
|
133
+7%
|
27
-80%
|
|
| Financing Cash Flow | ||||||||||||||||||
| Net Issuance of Common Stock |
176
|
306
|
295
|
294
|
295
|
116
|
117
|
115
|
349
|
236
|
237
|
239
|
7
|
22
|
20
|
17
|
15
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
18
|
18
|
|
| Other |
0
|
0
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(3)
|
(4)
|
(3)
|
(3)
|
(1)
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
232
N/A
|
306
+32%
|
294
-4%
|
292
-1%
|
293
+0%
|
116
-61%
|
116
+0%
|
114
-2%
|
346
+203%
|
232
-33%
|
234
+1%
|
236
+1%
|
6
-98%
|
22
+289%
|
20
-9%
|
36
+80%
|
34
-5%
|
|
| Change in Cash | ||||||||||||||||||
| Net Change in Cash |
165
N/A
|
242
+47%
|
217
-10%
|
113
-48%
|
11
-91%
|
(167)
N/A
|
(79)
+53%
|
30
N/A
|
238
+699%
|
133
-44%
|
(28)
N/A
|
(54)
-92%
|
(137)
-155%
|
(232)
-70%
|
(56)
+76%
|
(27)
+51%
|
(148)
-440%
|
|
| Free Cash Flow | ||||||||||||||||||
| Free Cash Flow |
(57)
N/A
|
(65)
-13%
|
(76)
-18%
|
(106)
-39%
|
(119)
-12%
|
(128)
-8%
|
(116)
+10%
|
(120)
-4%
|
(168)
-40%
|
(168)
+0%
|
(179)
-6%
|
(204)
-14%
|
(189)
+7%
|
(184)
+3%
|
(199)
-9%
|
(196)
+2%
|
(209)
-7%
|
|
Switch to:
Switch to:
See Also
Discover More
